SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Balance Sheets (USD $)	Jun. 30, 2011	Dec. 31, 2010
Cash	$ 261	$ 1,195
Accounts receivable	0	28,000
Total Current Assets	261	29,195
PROPERTY AND EQUIPMENT, NET	373	463
TOTAL ASSETS	634	29,658
Accounts payable	259,423	244,359
Accrued interest	5,270	2,330
Related party payable	264,141	182,675
Notes payable	140,200	29,700
Accrued compensation	0	6,075
Total Current Liabilities	669,034	465,139
Total Liabilities	669,034	465,139
Preferred stock, 10,000,000 shares authorized of $0.001 par value, 150,000 shares issued and outstanding, respectively	150	150
Common stock, 200,000,000 shares authorized of $0.001 par value, 6,704,572 and 6,682,072 shares issued and outstanding, respectively	6,705	6,682
Additional paid in capital	9,697,963	8,697,935
Preferred stock subscribed	0	8,500
Deficit accumulated during the development stage	(10,373,218)	(9,148,748)
Total Shareholders' Deficit	(668,400)	(435,481)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 634	$ 29,658